{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:27:08Z","timestamp":1793665628377,"version":"4.5.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"51","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,20]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Cerebral amyloid angiopathy-related inflammation (CAA-ri) is a treatable condition characterized by an acute or subacute onset, with its primary pathological hallmark being the deposition of amyloid, predominantly \u03b2-amyloid (A\u03b2), within intracranial microvessels. Despite its potential for treatment, CAA-ri is a rare disorder that is frequently underrecognized by clinicians in practice. This article provides a comprehensive overview of the clinical manifestations and therapeutic approaches associated with CAA-ri, aiming to enhance awareness among healthcare professionals.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 67-year-old male patient who suffered from a sudden decline in cognitive functioning, intermittent headache, and dysphoria underwent brain magnetic resonance imaging, susceptibility weighted imaging, and cerebrospinal fluid analysis and was considered probable CAA-ri.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis interventions:<\/jats:title>\n            <jats:p>During the course of disease development, the patient suffered from a sudden decline in cognitive functioning, mainly in the form of unresponsiveness, decreased comprehension, and increased repetitive language, accompanied by intermittent headaches and dysphoria. Brain magnetic resonance imaging showed numerous white matter in both hemispheres. Susceptibility weighted imaging showed multiple spots of hypointensity in the bilateral cerebral and cerebellar hemispheres, a hypointensity signal in the left occipital lobe, and extensive zones of hypointensity in bilateral sulci. Cerebrospinal fluid analysis was abnormal with elevated levels of protein and low levels of P-tau, A\u03b242, and A\u03b21-42\/A\u03b21-40. The use of glucocorticoids greatly reduced his symptoms. This lends credence to the probable CAA-ri diagnosis. The symptoms can be successfully alleviated by administering methylprednisolone sodium succinate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>During the patient\u2019s hospitalization, immunosuppressive therapy, primarily consisting of methylprednisolone sodium succinate and methylprednisolone, was administered, resulting in a significant improvement in symptoms. Post-discharge, the patient was monitored regularly, revealing a gradual enhancement in cognitive function without recurrence. Consequently, immunosuppressive therapy was discontinued 1 year following the patient\u2019s discharge.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>CAA-ri is a rare clinical condition, and timely diagnosis and early treatment are very critical for patient prognosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041010","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T20:03:24Z","timestamp":1734725004000},"page":"e41010","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cerebral amyloid angiopathy-related inflammation (CAA-ri): A case report"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5725-3911","authenticated-orcid":false,"given":"Yao","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Department of Neurology, Graduate School of Hebei North University, Zhangjiakou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Graduate School of Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Graduate School of North China University of Science and Technology, Tangshan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2505-8172","authenticated-orcid":false,"given":"Yanhong","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hebei General Hospital, Shijiazhuang, China"},{"name":"Department of Neurology, Graduate School of Hebei North University, Zhangjiakou, China"},{"name":"Hebei Provincial Key Laboratory of Cerebral Networks and Cognitive Disorders, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.3390\/ijms25052945","article-title":"Update on antioxidant therapy with edaravone: expanding applications in neurodegenerative diseases.","volume":"25","author":"Yamashita","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jphs.2020.05.002","article-title":"Xingnaojing ameliorates synaptic plasticity and memory deficits in an A\u03b21-42 induced mouse model of Alzheimer\u2019s disease.","volume":"143","author":"Liu","year":"2020","journal-title":"J Pharmacol Sci"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5853\/jos.2023.01942.e1","article-title":"Cerebral amyloid angiopathy: an undeniable small vessel disease.","volume":"26","author":"Wang","year":"2024","journal-title":"J Stroke"},{"key":"R4-20250503","first-page":"87","article-title":"Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon.","volume":"32","author":"Banerjee","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jns.2004.09.009","article-title":"Cerebral amyloid angiopathy and gene polymorphisms.","volume":"226","author":"Yamada","year":"2004","journal-title":"J Neurol Sci"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/alz.12366","article-title":"Prevalence of cerebral amyloid angiopathy: a systematic review and meta-analysis.","volume":"18","author":"J\u00e4kel","year":"2022","journal-title":"Alzheimers Dement"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"e230009","DOI":"10.1148\/rg.230009","article-title":"Amyloid-related imaging abnormalities in Alzheimer disease treated with anti-amyloid-\u03b2 therapy.","volume":"43","author":"Agarwal","year":"2023","journal-title":"Radiographics"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-151036","article-title":"Cerebral amyloid angiopathy (CAA)-related inflammation: comparison of inflammatory CAA and amyloid-\u03b2-related angiitis.","volume":"51","author":"Chu","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000260066.98681.2e","article-title":"Course of cerebral amyloid angiopathy-related inflammation.","volume":"68","author":"Kinnecom","year":"2007","journal-title":"Neurology"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jamaneurol.2015.4078","article-title":"Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation.","volume":"73","author":"Auriel","year":"2016","journal-title":"JAMA Neurol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/CM9.0000000000001427","article-title":"Cerebral amyloid angiopathy-related inflammation: current status and future implications.","volume":"134","author":"Wu","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"1153305","DOI":"10.3389\/fneur.2023.1153305","article-title":"Amyloid and tau PET in cerebral amyloid angiopathy-related inflammation two case reports and literature review.","volume":"14","author":"Yang","year":"2023","journal-title":"Front Neurol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jamaneurol.2020.1782","article-title":"Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation.","volume":"77","author":"Regenhardt","year":"2020","journal-title":"JAMA Neurol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/BF00687163","article-title":"Giant cell arteritis and arteriolitis associated with amyloid angiopathy in an elderly Mongol.","volume":"27","author":"Reid","year":"1974","journal-title":"Acta Neuropathol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"1219025","DOI":"10.3389\/fnins.2023.1219025","article-title":"Rare forms of cerebral amyloid angiopathy: pathogenesis, biological and clinical features of CAA-ri and iCAA.","volume":"17","author":"Storti","year":"2023","journal-title":"Front Neurosci"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.2174\/138161210793176545","article-title":"Neurotoxicity of \u03b2-amyloid protein: oligomerization, channel formation, and calcium dyshomeostasis.","volume":"16","author":"Kawahara","year":"2010","journal-title":"Curr Pharm Des"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.bcp.2013.12.018","article-title":"The role of amyloid-beta in the regulation of memory.","volume":"88","author":"Morley","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jamaneurol.2021.3989","article-title":"Transient focal neurological events in cerebral amyloid angiopathy and the long-term risk of intracerebral hemorrhage and death: a systematic review and meta-analysis.","volume":"79","author":"Sanchez-Caro","year":"2022","journal-title":"JAMA Neurol"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1111\/ene.15903","article-title":"Incidence and risk factors associated with seizures in cerebral amyloid angiopathy.","volume":"30","author":"Freund","year":"2023","journal-title":"Eur J Neurol"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/STROKEAHA.122.040671","article-title":"Clinical, neuroimaging, and genetic markers in cerebral amyloid angiopathy-related inflammation: a systematic review and meta-analysis.","volume":"54","author":"Theodorou","year":"2023","journal-title":"Stroke"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semarthrit.2014.02.001","article-title":"Amyloid beta-related angiitis\u2014a case report and comprehensive review of literature of 94 cases.","volume":"44","author":"Danve","year":"2014","journal-title":"Semin Arthritis Rheum"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:29:20Z","timestamp":1746318560000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":21,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041010","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}